|
|
Line 413: |
Line 413: |
| [[file:UK - Lion Shahab.jpg|center]] | | [[file:UK - Lion Shahab.jpg|center]] |
| *Disclosures: LS has received a research grant, honoraria for talks, consultancy and travel expenses to attend meetings and workshops from pharmaceutical companies that make smoking cessation products (Pfizer; Johnson & Johnson). He has never received any funding or other monetary benefits from the tobacco or e-cigarette industry. | | *Disclosures: LS has received a research grant, honoraria for talks, consultancy and travel expenses to attend meetings and workshops from pharmaceutical companies that make smoking cessation products (Pfizer; Johnson & Johnson). He has never received any funding or other monetary benefits from the tobacco or e-cigarette industry. |
| | <br> |
| | |
| | ===Erikas Simonavičius, PhD=== |
| | *[https://twitter.com/KingsNRG/status/1577654190301761536 Source] / [https://www.kcl.ac.uk/people/erikas-simonavicius Bio] |
| | [[file:UK Erikas Simonavičius.png|center]] |
| <br> | | <br> |
|
| |
|